Effect of Epidermal Growth Factor in the Rat / o Renal Ablation Model 1


Acute administration of epidermal growth factor (EGF) has been shown to promote recovery from ischemic and nephrotoxic acute renal failure in vivo. The question of whether chronic subcutaneous administration of EGF (19.1 pg/day for 3 or 6 wk) could alter the course of chronic renal failure in rats subjected to 5/6 nephrectomy was studied. By week 6, there… (More)


2 Figures and Tables

Slides referencing similar topics